Recombinant DNA Technology Market – By Types (Expression System and Cloning Vector), By Product (Medical and Non-Medical), By Application (Diseases, Plants, and Others), and By End User (Research Institutes, Biotechnology Companies, and Pharmaceuticals)

Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have augmented resistance to viruses and insect attacks, enhanced product yield, and shown increased adaptability for better survival.

Free PDF Sample Brochure on Recombinant DNA technology Market @ https://decisionmarketreports.com/request-sampleproductID=982959

Market Dynamics

Rapid technological advancements in the field of genetic engineering to deliver highly efficient therapeutics for disease management and in the field of agriculture are major driving factors for growth of recombinant DNA technology market. For instance, Bac-to-Bac Baculovirus Expression Systems offers a quick and efficient method to produce recombinant baculovirus and can express the desired genes in insect cells and provide high yields of recombinant protein that speeds up the cloning reaction as compared to the time-consuming restriction enzyme cloning, which takes 2–3 days. Also, in 2016, a BioAg Alliance was formed between Monsanto and Novozymes A/S, to improve crop harvests by using products containing naturally-occurring microbes to boost agricultural productivity and expand its product portfolio. However, the adoption of non-biologic therapeutics and higher complexity of the genetically engineered products such as stability of the cell lines, requirement of skilled professionals, and optimum temperature are the factors hindering the market growth.

Company Profiles

• Thermo Fisher Scientific, Inc.*
• Biogen, Inc.
• Sanofi Pasteur
• Merck & Co., Inc.
• Pfizer, Inc.
• Profacgen
• Amgen, Inc.
• Monsanto Company

Access Full Report @ https://decisionmarketreports.com/market-reports/982959/recombinant-dna-technology-market

Key features of the study:
• • This report provides in-depth analysis of recombinant DNA technology market and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
• • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• • It profiles leading players in the global recombinant DNA technology market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
• • Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen, Inc., and Monsanto Company
• • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• • The global recombinant DNA technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the recombinant DNA technology market

Detailed Segmentation:

• Global Recombinant DNA Technology Market, By Product Type:

• Recombinant Protein Drugs
o Insulin
o Human Growth Hormone
o Erythropoietin
o Interferon
o Blood Factors
o Colony Stimulating Factors
o Fusion Proteins
o Others
• Vaccines
• Genetically Modified Crops
• Expression Systems
o Prokaryotic Cells
o Mammalian Cells
o Yeats
o Insect
o Others
• Cell and Gene Therapy
• Gene Editing

• Global Recombinant DNA Technology Market, By Application:

• Therapeutics
• Agriculture
• Research

Table of Contents

1. Research Objective and Assumption
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Recombinant DNA Technology Market, By Product Type, 2015 – 2025, (US$ Billion)
5. Global Recombinant DNA Technology Market, By Application, 2015 – 2025, (US$ Billion)
6. Global Recombinant DNA Technology Market, By Region, 2015 – 2025, (US$ Billion)
7. Competitive Landscape
8. Section

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA

US Toll Free +18666051052
Email: sales@decisionmarketreports.com
Web: http://decisionmarketreports.com/

This release was published on openPR.